Can the Severe Acute Respiratory Syndrome Coronavirus 2 Polymerase Chain Reaction Cycle Threshold Value and Time From Symptom Onset to Testing Predict Infectivity?
| Errataetall: |
CommentOn: Clin Infect Dis. 2020 Dec 17;71(10):2663-2666. - PMID 32442256 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:71 |
|---|---|
| Enthalten in: |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 71(2020), 10 vom: 17. Dez., Seite 2667-2668 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Binnicker, Matthew J [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 25.03.2021 Date Revised 05.11.2021 published: Print CommentOn: Clin Infect Dis. 2020 Dec 17;71(10):2663-2666. - PMID 32442256 Citation Status MEDLINE |
|---|
| doi: |
10.1093/cid/ciaa735 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM310840635 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM310840635 | ||
| 003 | DE-627 | ||
| 005 | 20231225140951.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/cid/ciaa735 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1036.xml |
| 035 | |a (DE-627)NLM310840635 | ||
| 035 | |a (NLM)32504529 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Binnicker, Matthew J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Can the Severe Acute Respiratory Syndrome Coronavirus 2 Polymerase Chain Reaction Cycle Threshold Value and Time From Symptom Onset to Testing Predict Infectivity? |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.03.2021 | ||
| 500 | |a Date Revised 05.11.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: Clin Infect Dis. 2020 Dec 17;71(10):2663-2666. - PMID 32442256 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a PCR | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a cycle threshold | |
| 650 | 4 | |a infectivity | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |d 1992 |g 71(2020), 10 vom: 17. Dez., Seite 2667-2668 |w (DE-627)NLM012603007 |x 1537-6591 |7 nnns |
| 773 | 1 | 8 | |g volume:71 |g year:2020 |g number:10 |g day:17 |g month:12 |g pages:2667-2668 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/cid/ciaa735 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 71 |j 2020 |e 10 |b 17 |c 12 |h 2667-2668 | ||